Dr. Gene Tien joins CRA's Transfer Pricing Practice
CRA is pleased to announce that Dr. Gene Tien has joined the company as a vice president in the Transfer Pricing Practice.
This website will offer limited functionality in this browser. We only support the recent versions of major browsers like Chrome, Firefox, Safari, and Edge.
Gene Tien, PhD. is a vice president in Charles River Associates’ Transfer Pricing Practice.
Dr. Tien designs, values, and implements multinational intercompany pricing strategies, and advises on transfer pricing documentation, audit defense, and dispute resolution for US and non-US headquartered companies. He works with clients in a variety of industries to efficiently align and set high-value and intangible-generating transactions, while managing global tax and customs audit exposures. These industries include those in the digital economy, pharmaceuticals, medical devices, retail, oilfield / natural resource services, and the branded consumer product goods sectors.
Dr. Tien has over 25 years of experience in transfer pricing and economic valuation issues relating intangibles planning and controversy. He has participated in the successful conclusion of tax disputes, rulings, and bilateral arrangements in the US, and across Europe and Asia.
Prior to joining Charles River Associates, he advised law firms on transfer pricing planning and litigation matters for almost two decades after serving as an economist at PricewaterhouseCoopers in Chicago, Dallas, and Houston. While at Northwestern University, he specialized in Industrial Organization, studying technology transfer and the structure of licensing contracts.